June 10, 2021 12:41 PM EDT

A Washington CMO is doubling its manufacturing capacity, less than 5 years into its existence

Josh Sullivan

Just three years into its existence, Selkirk Pharma has started the expansion of its 145,000-square-foot fill-finish facility in Spokane, WA. The CMO will nearly double …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

A Washington CMO is doubling its manufacturing capacity, less than 5 years into its existence

Josh Sullivan

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Updated: Galapagos to split into two companies, slash headcount as it eyes turnaround

Astellas stops developing autologous cell therapy using tech from Xyphos buyout

MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment

Aiolos team reunites with $411M for new biotech with obesity drugs from China

Pfizer, GSK add risk of Guillain-Barré to RSV vaccine labels at FDA's request

A Wash­ing­ton CMO is dou­bling its man­u­fac­tur­ing ca­pac­i­ty, less than 5 years in­to its ex­is­tence

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

A Washington CMO is doubling its manufacturing capacity, less than 5 years into its existence